There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress: Indianapolis Monday, February 10, 20 ...
INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY), a pharmaceutical giant with a market capitalization of $783.7 billion ...
Conagra adds an ‘On Track’ badge on packaging for 26 of its Healthy Choice frozen meals that call out GLP-1 ...
U.S. stock futures are edging mostly higher as investors watch corporate earnings, Honeywell plans to split into three companies, and Qualcomm stock drops as its licensing revenue misses expectations.
Stay updated on the latest stock market trends and company earnings. Discover the impact of market gains and profit reports ...
More than 90% of Omvoh-treated patients who were in clinical remission at one year sustained it with two years of continuous treatment Omvoh works to reduce inflammation within the gastrointestinal ...
Wall Street drifted through a mixed day of trading as rising fashion and cigarette stocks worked against drops for Ford Motor ...
Wall Street drifted through mixed trading Thursday as rising fashion and cigarette stocks worked against drops for Ford Motor ...
Wall Street is drifting Thursday as gains for fashion brands and cigarette makers help offset drops for Ford Motor and ...
Eli Lilly has raised its revenue guidance for ... In its update, Ricks said a new facility at Concord in North Carolina – part of an $18 billion investment programme launched in 2020 – is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results